Arcus Biosciences, Inc.
RCUS· NYSE
Released May 9, 2018, after the close
10-Q filed May 9, 2018, 39 days after period end · 0001564590-18-012447
| Metric | Q1 2018 | Q1 2017 |
|---|---|---|
| Revenue | $1.25M | — |
| Net Income | -$12.95M | -$7.20M |
| EPS Diluted | -$1.37 | -$4.96 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end
3.1% from the close of May 9, 2018 to the close of May 10, 2018, the first after the release.